Phase II Clinical Trials Results of rhNRG-1 have been Published in JACC
2010-02-12
Zensun accomplished Chinese phase II clinical trial of rhNRG-1 in 2009. The article describing the results of this clinical trial has been accepted by JACC and will be published in the issue of May, 2010.
更多动态
Zensun is Collaborating with The Leibniz-Institut für Alternsforschung-Fritz-Lipmann-Institute.V. to Conduct a Preclinical Study of Neucardin® (recombinant human Neuregulin-1) for The Treatment of Schwannomas
ZENSUN ANNOUNCES THE INVESTIGATION OF NEUCARDIN FOR CHRONIC HEART FAILURE RECEIVES FAST TRACK DESIGNATION FROM THE US FDA
An International Multi-center Phase III Clinical Trial of Recombinant Human Neuregulin-1 is going to
